securities fraud

Class action lawsuit filed against Vistagen Therapeutics for alleged false statements regarding drug trial data. Investors who purchased securities April 2024-December 2025 may be eligible.

PayPal faces class action lawsuit alleging executives made false statements about revenue projections and 2027 financial targets, failing to disclose material risks to investors.

Portnoy Law Firm sues Richtech Robotics for falsely claiming Microsoft partnership. Stock fell 29% after Microsoft denied commercial relationship, causing investor losses.

Investors sued Ramaco Resources for allegedly misleading statements about Brook Mine operations between July-October 2025, claiming false progress claims.

Schall Law Firm sues Richtech Robotics for allegedly misrepresenting Microsoft partnerships. Investors who bought stock January 27-29, 2026 sought as plaintiffs.

PayPal faces securities lawsuit over allegedly false 2027 guidance and checkout platform claims. Investors who bought stock Feb 2025-Feb 2026 may seek compensation.

Rosen Law Firm sues Enphase Energy for allegedly misrepresenting inventory management and overstating financial outlook regarding tax credit impacts.

Kyndryl Holdings faces securities fraud lawsuit alleging material misrepresentations about cash management and internal financial controls, with delayed quarterly filings raising governance concerns.

Richtech Robotics faces securities lawsuit for misrepresenting Microsoft partnership scope. Stock dropped 29% after Microsoft clarified their relationship was limited to standard AI collaboration.

Oracle faces a securities class action lawsuit over allegedly misleading AI strategy disclosures. Investors must act by April 6, 2026, regarding stock purchased between June-December 2025.

GSI Technology faces securities investigation for allegedly making false claims about chip capabilities. Stock dropped 14.2% after disclosure that semiconductor couldn't run promised software.

Class action lawsuits filed against PomDoctor and Vistagen Therapeutics alleging securities violations. Vistagen's stock fell 80% after failed clinical trial results.

Varonis faces class action lawsuit over allegedly misleading statements about revenue sustainability. Investors have until March 9 to join after stock plunged 48.7%.

CoreWeave faces securities fraud lawsuit for allegedly misrepresenting operational capabilities and failing to disclose supplier concentration risk, causing investor losses during March-December 2025.

PayPal faces securities lawsuit alleging false revenue statements. Investors must file claims by April 20, 2026, following a 20.3% stock decline.

CoreWeave faces class action lawsuit alleging false statements about demand fulfillment and concealed risks from single supplier dependence. Investors from March-December 2025 can apply for lead plaintiff status by March 13, 2026.

Fermi Inc. stock plunged 33% after terminating a $150 million customer agreement. A securities fraud lawsuit was filed alleging misrepresentations in its IPO documents.

BellRing Brands faces securities fraud lawsuit after 33% stock decline. Company allegedly misrepresented sales growth as organic demand when driven by customer inventory buildup.

Kyndryl shares dropped 55% after accounting review revealed cash management issues. CFO and General Counsel departed amid SEC inquiry and fraud lawsuit filing.

Plug Power stock fell 17% after DOE suspended a $1.66 billion loan program. Shareholders filed a fraud lawsuit alleging inadequate disclosure of material information about the suspension.